Results 141 to 150 of about 14,752 (202)

Efgartigimod, an FcRn antagonist, as a potential treatment for post COVID-19 syndrome [PDF]

, 2023
Sandra E. Reznik, Amit K. Tiwari, Charles R. Ashby   +2 more
openalex   +1 more source

P049 Investigation into the binding affinity of certolizumab pegol to FcRn and functional consequences for FcRn-mediated transcytosis: comparison to infliximab, adalimumab and etanercept [PDF]

, 2014
Terry Baker, Lara Kevorkian, Andrew Nesbitt   +2 more
openalex   +1 more source

Does a Polycistronic 2A Design Enable Functional FcRn Production for Antibody Pharmacokinetic Studies? [PDF]

Pharmaceutics
Nesmeyanova VS, Ushkalenko ND, Olkin SE, Kosenko MN, Rukhlova EA, Susloparov IM, Shcherbakov DN.   +6 more
europepmc   +1 more source

Immunoglobulin G Fc engineering for localized therapy: Eliminating neonatal Fc receptor interactions and ensuring purification using protein A. [PDF]

Protein Sci
Kato A, Toshima A, Takekawa G, Miyagi H, Kubota A, Hori S, Uemura Y, Niwa R.   +7 more
europepmc   +1 more source

Catalytic degradation of circulating targets with FcRn-mediated cycling LYTACs

Christos Kougentakis, Matthew J. Shurtleff, Rachel M. Lieser, Tao Chen, C. B. Collins, Isabel Johnson, Siyi Gu, Keith T. Akama, Kyle H. Doran, Candice Fung, Darin J. Hildebrandt, Rozhan Khaleghi, Diana Li, Steve Rank, Thomas-Toan Tran, Richard G. Yau, Rick D. Holly, Chris Langsdorf, Darrin A. Lindhout, Sarah M. McWhirter, Jeffrey S. Iwig, J. Lewis, Steven T. Staben, Eric D. Turtle, Nicholas A. Lind   +24 more
openalex   +1 more source

Management of Myasthenic Crisis and Emerging Roles of Molecularly Targeted Therapies: A Narrative Review. [PDF]

Neurol Int
Takahashi S, Kinno R.
europepmc   +1 more source

Safety profile of complement C5 inhibitors and FcRn inhibitors in the treatment of myasthenia gravis: analysis of the FAERS database and disease-gene interaction network. [PDF]

Front Immunol
Wang L, Chen J, Li H, Wang L, Liu F, Jiang X.   +5 more
europepmc   +1 more source

Functional specialization and cooperation between the neonatal- and classical IgG receptors, FcRn and FcɣR

, 2014
H Einarsdottir
openalex   +1 more source

OP0041 Treatment of primary Sjögren's disease by blocking FcRn: clinical and translational data from RHO, a phase 2 randomized, placebo controlled, double-blind, proof-of-concept study with efgartigimod

Isabelle Peene, Gwenny M. Verstappen, Joke Deprez, Frans G. M. Kroese, S. Arends, Aaron S. Kelly, L. Vandersarren, E Frances Bowen, Johannes W. G. Jacobs, Paul Meyvisch, Dirk Elewaut, Hendrika Bootsma   +11 more
openalex   +1 more source

The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody–mediated amelioration of murine immune thrombocytopenia [PDF]

, 2011
Andrew R. Crow, Sara J. Suppa, Xi Chen, Patrick J. Mott, Alan H. Lazarus   +4 more
openalex   +1 more source